Keywords: Breast, biomarkers, neoadjuvant chemotherapy
Motivation: Accurate prediction of pathological completed response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer.
Goal(s): Evaluate the value of potential MRI biomarkers for predicting pCR and establish a new nomogram to improve predictive performance.
Approach: We conducted an analysis of 692 patients, utilizing univariable and multivariable logistic regression analyses, and training/validation cohorts for model development and validation.
Results: Our newly developed model, combining the selected MRI parameters, hormone receptor (HR) and Ki67 index, exhibited strong predictive power, and also identified the rimed enhancement pre-NAC, and tumor size, wash-in slope, and ADC after NAC as significant imaging biomarkers of pCR.
Impact: The impact of this study is significant, as it enhances breast cancer treatment by providing a reliable predictive model for neoadjuvant chemotherapy response, potentially improving patient outcomes and treatment strategies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords